FDA Accepts Genentech's SBLA forXolair for Chronic Idiopathic Urticaria
October 11, 2013 at 05:48 AM EDT
Genentech, a member of the Roche Group (OTC: RHHBY ), today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed the company's supplemental Biologics License
